← Back to Patent Explorer
US5024742A Expired / Lapsed US ⏱️ 0.0 years remaining

Method of crosslinking amino acid containing polymers using photoactivatable chemical crosslinkers

Assignee: Cedars-Sinai Medical Center
•
Filing: 1988-02-24
•
Granted: 1991-06-18
•
Expires: 2008-02-24
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method for molecularly crosslinking amino acid containing polymers by photoactivating chemical crosslinkers which have been combined with the polymers. Collagen crosslinked by this method can be used as a bioadhesive for sutureless closures of the skin and eye or as a superhydrated material for contact lenses, moist bandage contact lens, lens or corneal implant material, or as a drug delivery mechanism.

Inventors

  • 👤 Anthony B. Nesburn
  • 👤 Michael Gorin
  • 👤 Marvin Martinez
  • 👤 M. Cristina Kenney
  • 👤 Ezra Maguen

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 03:06
CPC Classifications
G; G03; G03F; G03F7/00; G03F7/004; G03F7/038; A; A61; A61L; A61L24/00; A61L24/04; A61L24/10; A61L24/102; A61L27/00; A61L27/14; A61L27/22; A61L27/24; C; C08; C08H; C08H1/00; C08H1/06; A61F; A61F2310/00; A61F2310/00005; A61F2310/00365; Y; Y10; Y10S; Y10S128/00; Y10S128/08

Claims Analysis

Total Claims: 27
Claim 1
Independent Claim 103 words
A method of crosslinking amino acid containing polymers unto themselves for in vivo applications by means of photoactivatable heterobifunctional crosslinking agents, said crosslinking agents have a photoactivatable site and a conventional site, which comprises: (a) selecting the amino acid containing polymers; (b) combining said amino acid containing polymers with said photoactivatable heterobifunctional crosslinking agents such that the conventional site on the crosslinking agent is bound to the polymer, and the other photoactivatable site on the crosslinking agent is unbound, photoactivating the crosslinked polymer to bind to another amino acid containing polymer, thereby forming a crosslinked amino acid containing polymer for in vivo application.
Claim 2
Independent Claim 103 words
A method of crosslinking amino acid containing polymers unto themselves for in vivo applications by means of photoactivatable heterobifunctional crosslinking agents, said crosslinking agents have a photoactivatable site and a conventional site, which comprises: (a) selecting the amino acid containing polymers; (b) combining said amino acid containing polymers with said photoactivatable heterobifunctional crosslinking agents such that the conventional site on the crosslinking agent is bound to the polymer, and the other photoactivatable site on the crosslinking agent is unbound, photoactivating the crosslinked polymer to bind to another amino acid containing polymer, thereby forming a crosslinked amino acid containing polymer for in vivo application.
Claim 3
Dependent Claim 15 words
A method as claimed in claim 1, wherein the amino acid containing polymer is collagen.
Claim 4
Dependent Claim 21 words
A method as claimed in claim 2, wherein the collagen is an Atelocollagen (e.g. Vitrogen 100) or Rat Tail Type I.
Claim 5
Dependent Claim 22 words
A method as claimed in claim 1, wherein the concentration of the amino-acid containing polymer is between 2.5 mg/ml to 10 mg/ml.
Claim 6
Dependent Claim 40 words
A method as claimed in claim 4, wherein the concentration is achieved by dialyzing the polymer against acetate buffer at pH 5, or by lyophilizing known quantities of the polymer and then resuspending in 0.012 HCl or CH 3 COOH.
Claim 7
Dependent Claim 20 words
A method as claimed in claim 1, wherein the pH of the amino-acid containing polymers range between 2.0 and 7.4.
Claim 8
Dependent Claim 23 words
A method as claimed in claim 1, wherein the photoactivatable heterobifunctional crosslinking agent is a diazo compound or an Aryl or Alkyl Azide.
Claim 9
Dependent Claim 25 words
A method as claimed in claim 1, wherein the photoactivatable heterobifunctional crosslinker is 4-azidobenzoic acid N-Hydroxysuccinimide Ester (HSAB) or 6-(-4-azido-2-nitrophenyl-amino) hexanoic acid N-hydroxysuccinimide Ester (SANAH).
Claim 10
Dependent Claim 16 words
A method as claimed in claim 1, wherein the crosslinking agent is dissolved in a solvent.
Claim 11
Dependent Claim 12 words
A method as claimed in claim 8, where the solvent is DMSO.
Claim 12
Dependent Claim 17 words
A method as claimed in claim 10, wherein the concentration of DMSO is between 50 and 100%.
Claim 13
Dependent Claim 23 words
A method as claimed in claim 1, wherein the concentration of the photoactivatable heretobifunctional crosslinking agent is between 5 mM and 25 mM.
Claim 14
Dependent Claim 41 words
A method as claimed in claim 1, wherein the photoactivation is achieved with a wave length range of 220 nanometers (nm) to 310 nm, with an optimum absorbing wavelength approximately 265 mm with a photoactivation time not to exceed 20 minutes.
Claim 15
Dependent Claim 30 words
A method as claimed in claim 1, wherein the solution of polymer and crosslinking agent prior to photoactivation, is run through a Sephadex G25 column to remove unbound crosslinking agent.
Claim 16
Dependent Claim 27 words
A method as claimed in claim 14, wherein fractions collected from the Sephadex G25 column are photometrically analyzed to determine and collect the peak polymer-crosslinking agent fractions.
Claim 17
Independent Claim 175 words
A method of crosslinking collagen for in vivo applications by means of photoactivatable heretobifunctional corsslinking agents, said crosslinking agents having a photoactivatable site and a conventional site, which comprises: (a) preparing a 9 mg/ml concentration of collagen molecules at pH 7.2; (b) dissolving said photoactivatable heretobifunctional crosslinking agents in DMSO such that the concentration of the crosslinking agent is 10 mM; (c) combining said collagen mixture with said photoactivatable heterobifunctional crosslinking agents, such that the conventional site on the crosslinking agent is bound to the collagen molecule, and the other photoactivatable site on the crosslinking agent is unbound, photoactivating the crosslinked polymer to bind to another collagen molecule, thereby forming a crosslinked amino acid containing polymer for in vivo application; (d) running the pre-photoactivated combination of collagen and crosslinking agent in Step (c) through a Sephadex G-25 column such that unbound crosslinking agent is removed; and (e) collecting fractions from the Sephadex G-25 column after Step (d) and running said fractions through a Spectrophotometer 260-320 nm such that peak collagen-crosslinking agent fractions can be collected.
Claim 18
Independent Claim 175 words
A method of crosslinking collagen for in vivo applications by means of photoactivatable heretobifunctional corsslinking agents, said crosslinking agents having a photoactivatable site and a conventional site, which comprises: (a) preparing a 9 mg/ml concentration of collagen molecules at pH 7.2; (b) dissolving said photoactivatable heretobifunctional crosslinking agents in DMSO such that the concentration of the crosslinking agent is 10 mM; (c) combining said collagen mixture with said photoactivatable heterobifunctional crosslinking agents, such that the conventional site on the crosslinking agent is bound to the collagen molecule, and the other photoactivatable site on the crosslinking agent is unbound, photoactivating the crosslinked polymer to bind to another collagen molecule, thereby forming a crosslinked amino acid containing polymer for in vivo application; (d) running the pre-photoactivated combination of collagen and crosslinking agent in Step (c) through a Sephadex G-25 column such that unbound crosslinking agent is removed; and (e) collecting fractions from the Sephadex G-25 column after Step (d) and running said fractions through a Spectrophotometer 260-320 nm such that peak collagen-crosslinking agent fractions can be collected.
Claim 19
Dependent Claim 30 words
Molecularly crosslinked amino acid containing polymers for in vivo applications, comprising photoactivating amino acid containing polymers in vivo with a photoactivated heterobifunctional crosslinking agent to produce crosslinking between the polymers.
Claim 20
Dependent Claim 30 words
Molecularly crosslinked amino acid containing polymers for in vivo applications, comprising photoactivating amino acid containing polymers in vivo with a photoactivated heterobifunctional crosslinking agent to produce crosslinking between the polymers.
Claim 21
Dependent Claim 35 words
A molecularly crosslinked collagen for in vivo applications, comprising photoactivating collagen molecules in vivo with a photoactivated heretobifunctional crosslinking agent, while in vivo, thereby forming a crosslinked amino acid containing polymer for in vivo application.
Claim 22
Dependent Claim 35 words
A molecularly crosslinked collagen for in vivo applications, comprising photoactivating collagen molecules in vivo with a photoactivated heretobifunctional crosslinking agent, while in vivo, thereby forming a crosslinked amino acid containing polymer for in vivo application.
Claim 23
Independent Claim 90 words
A method of preparing bioadhesives for in vivo applications by crosslinking amino acid containing polymers unto themselves by means of photoactivatable heretobifunctional crosslinking agents, said crosslinking agents having a photoactivatable site and a conventional site, comprising: (a) selecting amino acid containing polymers; and (b) combining said amino acid containing polymers with said photoactivatable heretobifunctional crosslinking agents such that the conventional site on the crosslinking agent is bound to the polymer, and the other photoactivatable site on the crosslinks is bound to another amino acid containing polymer, through in vivo photoactivation.
Claim 24
Independent Claim 90 words
A method of preparing bioadhesives for in vivo applications by crosslinking amino acid containing polymers unto themselves by means of photoactivatable heretobifunctional crosslinking agents, said crosslinking agents having a photoactivatable site and a conventional site, comprising: (a) selecting amino acid containing polymers; and (b) combining said amino acid containing polymers with said photoactivatable heretobifunctional crosslinking agents such that the conventional site on the crosslinking agent is bound to the polymer, and the other photoactivatable site on the crosslinks is bound to another amino acid containing polymer, through in vivo photoactivation.
Claim 25
Independent Claim 109 words
A method for preparing superhydrated acid containing polymers for in vivo applications by crosslinking amino acid containing polymers unto themselves by means of photoactivatable heterobifunctional crosslinking agents, said crosslinking agents having a photoactivatable site and a conventional site, comprising: (a) selecting amino acid containing polymers; and (b) combining said amino acid containing polymers with said photoactivatable heretobifunctional crosslinking agents such that the conventional site on the crosslinking agent is bound to the polymer, and the other photoactivatable site on the crosslinking agent is unbound, photoactivating the crosslinked polymer to bind to another amino acid containing polymer, thereby forming a superhydrated crosslinked amino acid containing polymer for in vivo application.
Claim 26
Independent Claim 109 words
A method for preparing superhydrated acid containing polymers for in vivo applications by crosslinking amino acid containing polymers unto themselves by means of photoactivatable heterobifunctional crosslinking agents, said crosslinking agents having a photoactivatable site and a conventional site, comprising: (a) selecting amino acid containing polymers; and (b) combining said amino acid containing polymers with said photoactivatable heretobifunctional crosslinking agents such that the conventional site on the crosslinking agent is bound to the polymer, and the other photoactivatable site on the crosslinking agent is unbound, photoactivating the crosslinked polymer to bind to another amino acid containing polymer, thereby forming a superhydrated crosslinked amino acid containing polymer for in vivo application.
Claim 27
Dependent Claim 13 words
A crosslinked amino acid containing polymer produced by the method of claim 1.

References Cited (Backward Citations)

US4505855A Cited
US4621631A Cited
US4511478A Cited
US4597999A Cited
US4883487A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1994-06-17 1994-12-17 1995-06-18 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1998-06-17 1998-12-17 1999-06-18 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2002-06-17 2002-12-17 2003-06-18 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag